Literature DB >> 17206667

Genetics of the innate immune response in inflammatory bowel disease.

Johan Van Limbergen1, Richard K Russell, Elaine R Nimmo, Gwo-Tzer Ho, Ian D Arnott, David C Wilson, Jack Satsangi.   

Abstract

The discovery of nucleotide-binding oligomerization domain 2/caspase recruitment domain-containing protein 15 (NOD2/CARD15) as the first susceptibility gene in Crohn's disease (CD) has shifted the focus of research into the pathogenesis of inflammatory bowel disease (IBD) firmly to the innate immune response and the integrity of the epithelial barrier. The subsequent implication in IBD of variant alleles of OCTN, DLG5, MDR1, and TLRs has provided further support for a new, more complex model of innate immunity function in the gastrointestinal tract. In this review, we examine the recent advances in our understanding of the influence of genetics of the innate immune response on IBD. We will focus on germline variation of genes encoding pathogen-recognition receptors, proteins involved in epithelial homeostasis and secreted antimicrobial proteins.

Entities:  

Mesh:

Year:  2007        PMID: 17206667     DOI: 10.1002/ibd.20096

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  20 in total

1.  IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland.

Authors:  J Van Limbergen; R K Russell; E R Nimmo; H E Drummond; L Smith; G Davies; N H Anderson; P M Gillett; P McGrogan; K Hassan; L Weaver; W M Bisset; G Mahdi; D C Wilson; J Satsangi
Journal:  Gut       Date:  2007-03-02       Impact factor: 23.059

Review 2.  Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update.

Authors:  Cansel Turkay; Benan Kasapoglu
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

Review 3.  Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles.

Authors:  Tomohiro Terada; Daiki Hira
Journal:  J Gastroenterol       Date:  2015-03-14       Impact factor: 7.527

Review 4.  Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?

Authors:  Eamonn M M Quigley
Journal:  Therap Adv Gastroenterol       Date:  2016-03       Impact factor: 4.409

5.  Susceptibility to ulcerative colitis in Hungarian patients determined by gene-gene interactions.

Authors:  Patricia Sarlos; Dalma Varszegi; Veronika Csongei; Lili Magyari; Luca Jaromi; Lajos Nagy; Bela Melegh
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 6.  Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis.

Authors:  Saleh A Naser; Melissa Arce; Anam Khaja; Marlene Fernandez; Najih Naser; Sammer Elwasila; Saisathya Thanigachalam
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

Review 7.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

8.  The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease.

Authors:  Masayuki Fukata; Keith Breglio; Anli Chen; Arunan S Vamadevan; Tyralee Goo; David Hsu; Daisy Conduah; Ruliang Xu; Maria T Abreu
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

9.  Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.

Authors:  Luciana Rigoli; Claudio Romano; Rosario Alberto Caruso; Maria A Lo Presti; Chiara Di Bella; Vincenzo Procopio; Giuseppina Lo Giudice; Maria Amorini; Giuseppe Costantino; Maria D Sergi; Caterina Cuppari; Giovanna Elisa Calabro; Romina Gallizzi; Carmelo Damiano Salpietro; Walter Fries
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

10.  The relevance of kinin B1 receptor upregulation in a mouse model of colitis.

Authors:  D B Hara; D F P Leite; E S Fernandes; G F Passos; A O Guimarães; J B Pesquero; M M Campos; J B Calixto
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.